IN DB/DB MICE, SGLT2 INHIBITION DOES NOT IMPROVE DIABETIC NEPHROPATHY DESPITE GLYCAEMIC IMPROVEMENTS

被引:0
|
作者
Gallo, L. A. [1 ]
Ward, M. S. [1 ]
Fotheringham, A. K. [1 ]
Pollock, C. [2 ]
Panchapakesan, U. [2 ]
Forbes, J. M. [1 ]
机构
[1] Univ Queensland, Mater Res Inst, Woolloongabba, Qld, Australia
[2] Univ Sydney, Kolling Inst Med Res, Sydney, NSW 2006, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
025
引用
收藏
页码:24 / 24
页数:1
相关论文
共 50 条
  • [21] Brazilin Ameliorates Diabetic Nephropathy and Inflammation in db/db Mice
    Li, Zhan-yuan
    Zheng, Yu
    Chen, Yan
    Pan, Min
    Zheng, Shu-bei
    Huang, Wen
    Zhou, Zhi-hong
    Ye, Han-yang
    [J]. INFLAMMATION, 2017, 40 (04) : 1365 - 1374
  • [22] Differential effect of statins on diabetic nephropathy in db/db mice
    Tamura, Yukinori
    Murayama, Toshinori
    Minami, Manabu
    Yokode, Masayuki
    Arai, Hidenori
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 (05) : 683 - 687
  • [23] Ezetimibe Ameliorates Early Diabetic Nephropathy in db/db Mice
    Tamura, Yukinori
    Murayama, Toshinori
    Minami, Manabu
    Matsubara, Takeshi
    Yokode, Masayuki
    Arai, Hidenori
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (07) : 608 - 618
  • [24] Urocortin ameliorates diabetic nephropathy in obese db /db mice
    Li
    Hu
    Zhang
    Sun
    Guan
    Chen
    Zhu
    [J]. 南京医科大学学报(自然科学版), 2008, (10) : 1311 - 1311
  • [25] DPP-4 inhibition with linagliptin delays the progression of diabetic nephropathy in db/db mice
    Sharkovska, Y.
    Alter, M.
    Reichetzeder, C.
    Tsuprykov, O.
    Klein, T.
    Hocher, B.
    [J]. DIABETOLOGIA, 2012, 55 : S20 - S20
  • [26] SGLT2 knockdown restores the Th17/Treg balance and suppresses diabetic nephropathy in db/db mice by regulating SGK1 via Na+
    Wang, Dan
    Zhang, Qian
    Dong, Wenhui
    Ren, Shijing
    Wang, Xiangyu
    Su, Cailin
    Lin, Xiaochun
    Zheng, Zongji
    Xue, Yaoming
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2024, 584
  • [27] Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy
    Gao, Qing
    Shen, Wenwen
    Qin, Weisong
    Zheng, Chunxia
    Zhang, Mingchao
    Zeng, Caihong
    Wang, Shengyu
    Wang, Jianping
    Zhu, Xiaodong
    Liu, Zhihong
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (11) : 3539 - 3547
  • [28] Inhibition of albumin glycation ameliorates diabetic nephropathy in the db/db mouse
    Clements, R
    Masson, N
    Cohen, M
    [J]. DIABETES, 1998, 47 : A52 - A52
  • [29] SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE
    Wang, Xiaoxin X.
    Levi, Jonathan
    Luo, Yuhuan
    Myakala, Komuraiah
    Herman-Edelstein, Michal
    Qiu, Liru
    Wang, Dong
    Peng, Yingqiong
    Grenz, Almut
    Lucia, Scott
    Dobrinskikh, Evgenia
    D'Agati, Vivette D.
    Koepsell, Hermann
    Kopp, Jeffrey B.
    Rosenberg, Avi Z.
    Levi, Moshe
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (13) : 5335 - 5348
  • [30] Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
    Gallo, Linda A.
    Ward, Micheal S.
    Fotheringham, Amelia K.
    Zhuang, Aowen
    Borg, Danielle J.
    Flemming, Nicole B.
    Harvie, Ben M.
    Kinneally, Toni L.
    Yeh, Shang-Ming
    McCarthy, Domenica A.
    Koepsell, Hermann
    Vallon, Volker
    Pollock, Carol
    Panchapakesan, Usha
    Forbes, Josephine M.
    [J]. SCIENTIFIC REPORTS, 2016, 6